These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


497 related items for PubMed ID: 16982827

  • 1. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
    Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG.
    Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
    [Abstract] [Full Text] [Related]

  • 2. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.
    Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
    Orr B, Douce G, Baillie S, Parton R, Coote J.
    Vaccine; 2007 Jan 02; 25(1):64-71. PubMed ID: 16916566
    [Abstract] [Full Text] [Related]

  • 4. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
    Khosravani A, Parker MC, Parton R, Coote J.
    Vaccine; 2007 May 30; 25(22):4361-7. PubMed ID: 17434242
    [Abstract] [Full Text] [Related]

  • 5. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, Nouzé C, Ladant D, Cole ST, Sebo P, Leclerc C.
    Infect Immun; 2006 Apr 30; 74(4):2128-37. PubMed ID: 16552042
    [Abstract] [Full Text] [Related]

  • 6. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate.
    Lim A, Ng JK, Locht C, Alonso S.
    Microbes Infect; 2014 Jan 30; 16(1):51-60. PubMed ID: 24140230
    [Abstract] [Full Text] [Related]

  • 7. Functional and structural studies on different forms of the adenylate cyclase toxin of Bordetella pertussis.
    Cheung GY, Kelly SM, Jess TJ, Prior S, Price NC, Parton R, Coote JG.
    Microb Pathog; 2009 Jan 30; 46(1):36-42. PubMed ID: 18992319
    [Abstract] [Full Text] [Related]

  • 8. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ, Gremmer ER, Vermeulen JP, Hellwig SM, Dormans JA, Roholl PJ, Mooi FR.
    Vaccine; 2007 Mar 08; 25(12):2346-60. PubMed ID: 17224216
    [Abstract] [Full Text] [Related]

  • 9. Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo.
    Xing DK, Canthaboo C, Corbel MJ.
    Vaccine; 2000 Apr 14; 18(20):2110-9. PubMed ID: 10715525
    [Abstract] [Full Text] [Related]

  • 10. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C.
    J Virol; 2005 Aug 14; 79(15):9872-84. PubMed ID: 16014948
    [Abstract] [Full Text] [Related]

  • 11. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M, Nagai M.
    Infect Immun; 2001 Nov 14; 69(11):6981-6. PubMed ID: 11598073
    [Abstract] [Full Text] [Related]

  • 12. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations.
    Hormozi K, Parton R, Coote J.
    Dev Biol Stand; 1999 Nov 14; 101():147-54. PubMed ID: 10566788
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice.
    Hormozi K, Parton R, Coote J.
    FEMS Immunol Med Microbiol; 1999 Apr 14; 23(4):273-82. PubMed ID: 10225286
    [Abstract] [Full Text] [Related]

  • 14. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
    van den Berg BM, David S, Beekhuizen H, Mooi FR, van Furth R.
    Vaccine; 2000 Dec 08; 19(9-10):1118-28. PubMed ID: 11137247
    [Abstract] [Full Text] [Related]

  • 15. Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.
    Ross PJ, Lavelle EC, Mills KH, Boyd AP.
    Infect Immun; 2004 Mar 08; 72(3):1568-79. PubMed ID: 14977963
    [Abstract] [Full Text] [Related]

  • 16. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death.
    Boyd AP, Ross PJ, Conroy H, Mahon N, Lavelle EC, Mills KH.
    J Immunol; 2005 Jul 15; 175(2):730-8. PubMed ID: 16002668
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transcriptional responses of murine macrophages to the adenylate cyclase toxin of Bordetella pertussis.
    Cheung GY, Dickinson P, Sing G, Craigon M, Ghazal P, Parton R, Coote JG.
    Microb Pathog; 2008 Jan 15; 44(1):61-70. PubMed ID: 17890046
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.